Favorable response to doxorubicin combination chemotherapy does not yield good clinical outcome in patients with metastatic breast cancer with triple-negative phenotype
about
The relationship between nuclear factor (NF)-κB family gene expression and prognosis in triple-negative breast cancer (TNBC) patients receiving adjuvant doxorubicin treatment.The value of cytoplasmic Y-box-binding protein 1 as a prognostic marker for breast cancer in Korean.Chemotherapy response assay test and prognosis for breast cancer patients who have undergone anthracycline- and taxane-based chemotherapy.MicroRNA Profile in Response to Doxorubicin Treatment in Breast Cancer.Clinical efficacy of local targeted chemotherapy for triple-negative breast cancer.
P2860
Favorable response to doxorubicin combination chemotherapy does not yield good clinical outcome in patients with metastatic breast cancer with triple-negative phenotype
description
2010 nî lūn-bûn
@nan
2010 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Favorable response to doxorubi ...... with triple-negative phenotype
@ast
Favorable response to doxorubi ...... with triple-negative phenotype
@en
type
label
Favorable response to doxorubi ...... with triple-negative phenotype
@ast
Favorable response to doxorubi ...... with triple-negative phenotype
@en
prefLabel
Favorable response to doxorubi ...... with triple-negative phenotype
@ast
Favorable response to doxorubi ...... with triple-negative phenotype
@en
P2093
P2860
P356
P1433
P1476
Favorable response to doxorubi ...... with triple-negative phenotype
@en
P2093
Do Hyoung Lim
Eun Yoon Cho
Hyun Jung Jun
Ji Eun Uhm
Jin Seok Ahn
Kyoung Ha Kim
Min Jae Park
Myung Hee Chang
Sang Hoon Ji
Seong Yoon Yi
P2860
P2888
P356
10.1186/1471-2407-10-527
P407
P577
2010-10-05T00:00:00Z
P5875
P6179
1002390285